Celebrating the 90th birthday of the scientist who discovered statins: Akira Endō

Stanisław Surma,Dimitri P Mikhailidis,Maciej Banach
DOI: https://doi.org/10.1093/eurheartj/ehad831
IF: 39.3
2024-01-09
European Heart Journal
Abstract:In 1971, Dr Akira Endō ( Figure 1A ), working at the Sankyo company in Tokyo, speculated that fungi not only contained antibiotics but also inhibitors of other processes, such as cholesterol metabolism. Over a period of several years, he screened >6000 fungal cultures until a positive result emerged. 1 This compound, which was named compactin (mevastatin), came from the blue-green mould Penicillium citrinum Pen-5 that was isolated from a rice sample collected at a grain shop in Kyoto. Based on biochemical assays, compactin (mevastatin) ( Figure 1B ) is the first known statin. 1 On 14 November 2023, Dr Akira Endō celebrated his 90th birthday. His discovery not only made statins the gold standard for lipid-lowering treatment (LLT), but also changed the natural history of cardiovascular (CV) disease (CVD) treatment and prolonged the lives of patients, both in primary and secondary cardiovascular prevention. 2 For the past decades, statins are the most commonly used 'cardiology' drugs in the world. 2 After over 50 years of natural 'statin history', we have prepared a SWOT (strengths, weaknesses, opportunities, and threats) analysis to summarize where we are and why we still underuse these drugs.
cardiac & cardiovascular systems
What problem does this paper attempt to address?